Transforming growth factor-beta 1 pathway components (TGF-beta 1 pathway)

The Transforming growth factor-beta 1 (TGF-beta 1) pathway is a fundamental signaling cascade that regulates a wide array of cellular processes, including growth, differentiation, and immune homeostasis. The pathway is initiated by the binding of the TGF-beta 1 cytokine to a heterotetrameric complex of type I (TGFBR1/ALK5) and type II (TGFBR2) serine/threonine kinase receptors, which subsequently phosphorylate downstream SMAD transcription factors (SMAD2/3). In normal physiology and early-stage cancer, the pathway acts as a potent tumor suppressor by inducing cell cycle arrest and apoptosis. However, in advanced disease states, it undergoes a functional switch to promote tumor progression, metastasis, and immune evasion, while also serving as the primary driver of pathological fibrosis across various organs. Therapeutic interventions targeting this pathway include neutralizing antibodies, small-molecule kinase inhibitors, and ligand traps, though their clinical application is complicated by the pathway's pleiotropic nature and the risk of systemic side effects.

Other names

TGFB1 pathwayTGF-beta signaling pathwayTGF-beta/Smad signaling pathwayTransforming growth factor-beta signaling components

Ligand neutralization, receptor serine/threonine kinase inhibition, ligand sequestration (traps), and antisense-mediated inhibition of ligand synthesis.